Free Trial

William Blair Has Pessimistic Outlook of Avantor Q3 Earnings

Avantor logo with Medical background

Avantor, Inc. (NYSE:AVTR - Free Report) - Research analysts at William Blair dropped their Q3 2025 earnings per share (EPS) estimates for shares of Avantor in a report issued on Friday, February 7th. William Blair analyst M. Larew now expects that the company will earn $0.28 per share for the quarter, down from their previous forecast of $0.29. The consensus estimate for Avantor's current full-year earnings is $0.98 per share. William Blair also issued estimates for Avantor's FY2025 earnings at $1.11 EPS.

Several other analysts also recently commented on the stock. Royal Bank of Canada decreased their price objective on shares of Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research report on Monday. Morgan Stanley lowered their price objective on Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Monday. UBS Group reiterated a "neutral" rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Stifel Nicolaus lowered their price target on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a report on Monday. Finally, Wells Fargo & Company dropped their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research note on Monday. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $26.15.

Read Our Latest Stock Analysis on AVTR

Avantor Price Performance

NYSE:AVTR traded up $0.07 during trading hours on Monday, hitting $18.12. 6,265,783 shares of the stock traded hands, compared to its average volume of 5,451,938. The company has a market cap of $12.33 billion, a price-to-earnings ratio of 39.38, a price-to-earnings-growth ratio of 3.87 and a beta of 1.28. Avantor has a 1 year low of $17.90 and a 1 year high of $28.00. The stock has a 50 day moving average price of $21.57 and a 200 day moving average price of $23.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping analysts' consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same period in the previous year, the business earned $0.22 earnings per share.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AVTR. Louisiana State Employees Retirement System lifted its stake in shares of Avantor by 0.3% in the 4th quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company's stock valued at $3,980,000 after purchasing an additional 500 shares during the last quarter. Hantz Financial Services Inc. lifted its position in Avantor by 2.1% in the third quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company's stock worth $644,000 after buying an additional 503 shares during the last quarter. Blue Trust Inc. boosted its stake in Avantor by 6.9% during the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock worth $170,000 after buying an additional 522 shares during the period. Pacer Advisors Inc. increased its position in Avantor by 0.5% during the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company's stock valued at $2,103,000 after acquiring an additional 542 shares during the last quarter. Finally, Veracity Capital LLC raised its stake in shares of Avantor by 1.0% in the third quarter. Veracity Capital LLC now owns 52,359 shares of the company's stock valued at $1,355,000 after acquiring an additional 543 shares during the period. Hedge funds and other institutional investors own 95.08% of the company's stock.

Avantor Company Profile

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Earnings History and Estimates for Avantor (NYSE:AVTR)

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines